Literature DB >> 21187449

CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].

Christelle de Brito1, Martine Tomkowiak, Raffaella Ghittoni, Christophe Caux, Yann Leverrier, Jacqueline Marvel.   

Abstract

Cross-presentation of cell-associated Ags by dendritic cells (DC) plays an important role in immunity. DC in lymphoid tissues are short lived, being continuously replaced by precursors that proliferate and differentiate locally. Paradoxically, although TLR ligands promote immune responses and stimulate DC replenishment, they impair the cross-priming capacity of terminally differentiated splenic CD8α(+) DC, the major subset involved in cross-priming. In this study, we have investigated the cross-presentation capacity of newly generated murine DC and especially immediate precursors of CD8α(+) DC. We show that these DC do not cross-present Ag from dead cells unless stimulated by TLR ligands before Ag capture. TLR ligand CpG induced the expression of costimulatory molecules required for CD8 T cell activation but also regulated the intracellular mechanisms of cross-presentation such as Ag degradation rates without regulating Ag uptake. GM-CSF, an inflammatory cytokine associated with infections, also promoted cross-presentation acquisition by pre-CD8α(+) DC and synergized with TLR9 ligand. The concept that TLR ligands as well as inflammatory cytokines promote the acquisition of cross-presenting properties by pre-CD8α(+) DC has important implications during immune responses and when considering the use of these cells for vaccination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21187449     DOI: 10.4049/jimmunol.1001022

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.

Authors:  Kuan-Yin Shen; Ying-Chyi Song; I-Hua Chen; Chih-Hsiang Leng; Hsin-Wei Chen; Hui-Ju Li; Pele Chong; Shih-Jen Liu
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

2.  Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system.

Authors:  Liang Cheng; Zheng Zhang; Guangming Li; Feng Li; Li Wang; Liguo Zhang; Sandra M Zurawski; Gerard Zurawski; Yves Levy; Lishan Su
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

Review 3.  Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm.

Authors:  Aakanksha Jain; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

4.  Basophils as a primary inducer of the T helper type 2 immunity in ovalbumin-induced allergic airway inflammation.

Authors:  Wenwei Zhong; Wen Su; Yanjie Zhang; Qi Liu; Jinhong Wu; Caixia Di; Zili Zhang; Zhenwei Xia
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 5.  Re(de)fining the dendritic cell lineage.

Authors:  Ansuman T Satpathy; Xiaodi Wu; Jörn C Albring; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2012-11-16       Impact factor: 25.606

6.  Effective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.

Authors:  Britnie R James; Erik L Brincks; Tamara A Kucaba; Louis Boon; Thomas S Griffith
Journal:  Cancer Immunol Immunother       Date:  2014-04-08       Impact factor: 6.968

Review 7.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

Review 8.  Transcriptional Control of Dendritic Cell Development.

Authors:  Theresa L Murphy; Gary E Grajales-Reyes; Xiaodi Wu; Roxane Tussiwand; Carlos G Briseño; Arifumi Iwata; Nicole M Kretzer; Vivek Durai; Kenneth M Murphy
Journal:  Annu Rev Immunol       Date:  2015-12-23       Impact factor: 28.527

9.  Primary sterile necrotic cells fail to cross-prime CD8(+) T cells.

Authors:  Jaba Gamrekelashvili; Lars A Ormandy; Markus M Heimesaat; Carsten J Kirschning; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

Review 10.  Particle platforms for cancer immunotherapy.

Authors:  Rita Elena Serda
Journal:  Int J Nanomedicine       Date:  2013-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.